SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$0.60
+0.06 (+11.59%)
Open$0.55
Previous Close$0.54
Day High$0.60
Day Low$0.53
52W High$13.63
52W Low$0.80
Volume—
Avg Volume222.7K
Market Cap4.81M
P/E Ratio—
EPS$-26.48
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Net Income | 119.2K | 97.1K | 110.6K |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |
| Rev Growth | +15.9% | +11.7% | +12.8% |
| Debt/Equity | 0.66 | 0.73 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |